News from bausch health companies inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Feb 24, 2021, 06:59 ET Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2020 Results And Provides 2021 Guidance

Fourth-Quarter 2020 Financial Results Revenues of $2.213 Billion GAAP Cash Generated from Operations of $394 Million GAAP Net Loss of $153 Million...

Feb 24, 2021, 06:45 ET Bausch Health Announces Agreement With Carl C. Icahn

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") is pleased to announce that it will expand its Board of Directors...

Feb 23, 2021, 07:00 ET Bausch + Lomb Launches Alaway® Preservative Free Antihistamine Eye Drops

Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced the U.S....

Feb 22, 2021, 07:00 ET Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it will reduce debt by $100 million through the...

Feb 18, 2021, 08:30 ET Salix Announces 2021 Gastrointestinal Health Scholars Program

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology (GI) business, Salix Pharmaceuticals, ("Salix"), one of the...

Feb 16, 2021, 07:00 ET Bausch Health Announces Participation In Upcoming Investor Conferences

Bausch Health Companies Inc. (NYSE: BHC, TSX: BHC) ("Bausch Health" or the "Company") today announced that the Company will participate in three...

Feb 11, 2021, 21:26 ET Bausch Health Responds To Schedule 13D Filing From Icahn Capital LP

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") issued the following statement in response to the Schedule 13D filed...

Feb 09, 2021, 07:00 ET Bausch Health Announces VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%, is Now Approved in South Korea

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company"), Bausch + Lomb, a leading global eye health business, and Nicox...

Feb 02, 2021, 07:00 ET Ortho Dermatologics Announces 2021 Aspire Higher Scholarship Program

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its dermatology business, Ortho Dermatologics, one of the largest prescription...

Feb 01, 2021, 07:00 ET Prevent Blindness and Bausch + Lomb to Launch Year-Long Video Series to Raise Awareness of Age-Related Macular Degeneration (AMD)

Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), and Prevent Blindness, the...

Jan 27, 2021, 07:00 ET Bausch Health Companies Inc. Will Release Fourth-Quarter And Full-Year 2020 Financial Results On February 24

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its fourth-quarter and full-year 2020 financial results on Wednesday, Feb....

Jan 21, 2021, 07:00 ET South Korea's MFDS Approves LUMIFY® Eye Drops

Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that LUMIFY®...

Jan 20, 2021, 07:00 ET Bausch + Lomb Announces Scientific Data On Bausch + Lomb INFUSE™ Silicone Hydrogel Daily Disposable Contact Lenses To Be Presented At The Virtual Global Specialty Lens Symposium

Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that two...

Jan 19, 2021, 07:00 ET Bausch + Lomb Completes Enrollment Of First Phase 3 Study For NOV03 (perfluorohexyloctane)

Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company"), and Novaliq...

Jan 12, 2021, 16:15 ET Bausch Health Provides Preliminary Update On Fourth-Quarter And Full-Year 2020 Financial Results And Business Recovery

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") will provide a preliminary update on its fourth-quarter and full-year ...

Jan 06, 2021, 07:00 ET Bausch Health To Participate At The 39th Annual J.P. Morgan Healthcare Conference

Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that Joseph C. Papa, chairman and chief executive officer, is scheduled to participate...

Dec 30, 2020, 07:00 ET Bausch Health's DEXAVEN (Dexamethasone Phosphate) Receives New Indication In Poland To Treat Patients With SARS-CoV-2 (COVID-19)

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that the Office for Registration of Medicinal Products, Medical...

Dec 29, 2020, 07:00 ET Bausch Health To Reduce Debt By $275 Million

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that on Dec. 31, 2020 it will pay down an additional...

Nov 24, 2020, 07:00 ET Bausch Health Initiates Second Phase 3 Study For NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") and Bausch + Lomb, its leading global eye health business, announced...

Nov 18, 2020, 16:51 ET Bausch Health Announces Pricing And Upsize Of Private Offering Of Senior Notes And Conditional Redemption Of Additional Series Of Existing Senior Notes

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has priced and upsized its previously...

Nov 18, 2020, 07:08 ET Bausch Health Announces Launch Of Private Offering Of Senior Notes And Conditional Redemption Of Existing Senior Notes

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has launched an offering of a combined $1.75...

Nov 16, 2020, 07:00 ET Bausch Health Announces Investigational In Vitro Data Indicating Complete Inactivation Of SARS-CoV-2 With LUMIFY® And BESIVANCE® Eye Drops Preserved With Benzalkonium Chloride

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and Bausch + Lomb, its leading global eye health business, today announced the results ...

Nov 12, 2020, 06:59 ET Bausch + Lomb Reports Nearly 27 Million Units of Contact Lens Materials Recycled Through One By One Recycling Program

Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that its...

Nov 11, 2020, 07:00 ET Salix To Present Data At AASLD's The Liver Meeting Digital Experience